This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Takeda Pharmaceutical Company Limited, Hitachi Global Storage Technologies Netherlands B.v.. Active years: 2008-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2008-2017
Title: Toru Miyazaki: Innovator in Cancer Treatment
Introduction
Toru Miyazaki is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. With a total of 5 patents to his name, Miyazaki's work is recognized for its potential impact on medical science.
Latest Patents
Miyazaki's latest patents focus on heterocyclic compounds that are useful for the prophylaxis or treatment of cancer. The inventions relate to compounds represented by specific formulas, which are detailed in the specifications of the patents. These compounds may also include salts or prodrugs that enhance their efficacy in cancer treatment.
Career Highlights
Throughout his career, Toru Miyazaki has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Takeda Pharmaceutical Company Limited and Hitachi Global Storage Technologies Netherlands B.V. His experience in these organizations has contributed to his expertise in developing innovative solutions for healthcare challenges.
Collaborations
Miyazaki has collaborated with several professionals in his field, including Misaki Homma and Yuya Oguro. These partnerships have likely facilitated the advancement of his research and the successful development of his patented compounds.
Conclusion
Toru Miyazaki stands out as an inventor dedicated to improving cancer treatment through innovative compounds. His contributions to the pharmaceutical industry reflect a commitment to advancing medical science and enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile